A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
about
Subversion of host recognition and defense systems by Francisella sppBiosynthetic origin of the galactosamine substituent of Arabinogalactan in Mycobacterium tuberculosisEvidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid ATLR-dependent control of Francisella tularensis infection and host inflammatory responsesRationally designed tularemia vaccines.Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in miceThe Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studiesFTT0831c/FTL_0325 contributes to Francisella tularensis cell division, maintenance of cell shape, and structural integrity.A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemiaAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.Macrophage replication screen identifies a novel Francisella hydroperoxide resistance protein involved in virulence.LPS remodeling is an evolved survival strategy for bacteria.The cell envelope glycoconjugates of Mycobacterium tuberculosisWhole genome sequencing of the fish pathogen Francisella noatunensis subsp. orientalis Toba04 gives novel insights into Francisella evolution and pathogenecity.Elucidation of a novel lipid A α-(1,1)-GalA transferase gene (rgtF) from Mesorhizobium loti: Heterologous expression of rgtF causes Rhizobium etli to synthesize lipid A with α-(1,1)-GalA.Discovery of new biosynthetic pathways: the lipid A story.A rapid one-step method for the characterization of membrane lipid remodeling in Francisella using matrix-assisted laser desorption ionization time-of-flight tandem mass spectrometry.Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia.Francisella tularensis subsp. tularensis induces a unique pulmonary inflammatory response: role of bacterial gene expression in temporal regulation of host defense responsesFrancisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide o-antigen, core and lipid a and affects intramacrophage survival and vaccine efficacy.Vaccines against tularemia.Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation.Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.The presence of a galactosamine substituent on the arabinogalactan of Mycobacterium tuberculosis abrogates full maturation of human peripheral blood monocyte-derived dendritic cells and increases secretion of IL-10.Role of Francisella lipid A phosphate modification in virulence and long-term protective immune responses.Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.Inhaled therapeutics for prevention and treatment of pneumoniaNorharmane Matrix Enhances Detection of Endotoxin by MALDI-MS for Simultaneous Profiling of Pathogen, Host, and Vector Systems.Repression of bacterial lipoprotein production by Francisella novicida facilitates evasion of innate immune recognitionA spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.Elucidation of the 3-O-deacylase gene, pagL, required for the removal of primary β-hydroxy fatty acid from the lipid A in the nitrogen-fixing endosymbiont Rhizobium etli CE3Bacterial strategies of resistance to antimicrobial peptides.Metabolic labeling to characterize the overall composition of Francisella lipid A and LPS grown in broth and in human phagocytes.Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.NaxD is a deacetylase required for lipid A modification and Francisella pathogenesisWorking toward the future: insights into Francisella tularensis pathogenesis and vaccine development.Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia.The atypical lipopolysaccharide of Francisella.
P2860
Q27025594-86B7E704-7BAF-4CB2-97C8-F2E92A00F41EQ28487338-E33FB392-7582-4D9F-994B-0FAA8CE55A4DQ28552005-0D6F966D-7FA6-4AD1-B38F-B9B2CE688C81Q28750216-87FD605A-EE33-4C39-9F54-D098017503F7Q30436251-D182212C-82AD-48D4-87E9-05EB63688A72Q33379774-654B8571-E5F0-49D9-B1F4-2F09CC14693EQ33550808-7ABEBAD6-7994-4776-A1C9-2DB2074C7B36Q33899765-EE780939-053C-452C-9631-9F374B1CB95EQ33983961-9FC75564-0568-4C03-8C11-6567F4E30811Q33995843-D401D718-C696-4D53-A841-58F871510AECQ34018936-A7A1D9A6-7FC9-4366-8F59-D55DA75AC057Q34268931-0AE30687-A562-4FBE-AC8B-12A79C0700F6Q34423962-B5F4AA2C-CED9-4BE8-93FF-A49F45462439Q34468356-7A32E5EA-A761-4161-9575-02B847FBC14AQ34530835-FB2B2D71-3B31-4386-A0F9-7891DA923EF0Q34599513-C0E04BA7-633D-421D-9E7A-A75AF888F3E8Q34711643-1FD6C6C0-0843-4221-B1C5-39D80FEEEB2DQ34714290-CC2C4852-F81D-42D2-A8B9-D12DA2403316Q34729832-9C43ED4D-B635-4670-BE22-8666BD69EA62Q35029406-3B428A17-CA09-4C78-A823-A905C20837E9Q35095362-0F850E4D-B093-4927-9282-A412FB8F1866Q35300228-4C833D0D-C014-472D-B750-03684FA962A5Q35541353-134A078A-22ED-4CC0-951D-042A18689B05Q35762782-81546E86-2110-4C0F-B7D6-B3D65C30DAD5Q35805338-EB4D5620-69A4-4876-9D66-24CFCF81458BQ35835988-C66BD1E5-640B-4187-B143-55DD14AD1544Q35925366-545E85AE-32DE-4525-ACE3-081BD256D54BQ36138907-AC2A546C-5C92-469F-91E3-48A883D66C76Q36236696-E0743125-FF79-4416-BA1A-3DDB2263951FQ36318241-D3E5B109-28FB-40E9-88E3-3D193BF8787AQ36613357-304DCFFC-1042-4F13-946A-A203F8B30B16Q36796851-F5D72992-313E-4061-B883-FD20E0391F33Q36920921-C8E351EE-77A0-4249-A73C-7FBD493F0775Q37228144-2394B774-A52C-476B-8C86-8EFC32614DCAQ37263796-2AC5365C-28C5-4860-ADDC-37A377F46FEAQ37287818-B59B6952-9A7C-4CA3-BCBF-A76A96099A3DQ37345795-EE6790FA-2C82-4C28-9A70-55B4AC6BF8FAQ37451520-0035ED09-1DF2-4BFE-8CC0-8F2F26B14393Q38008395-37F309B1-329C-4B87-A9FD-52F7942D1076Q38126673-9C6E015A-AF03-415A-9DC5-2729E85A2851
P2860
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@ast
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@en
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@nl
type
label
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@ast
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@en
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@nl
prefLabel
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@ast
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@en
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.
@nl
P2093
P2860
P1433
P1476
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity
@en
P2093
Duangjit Kanistanon
Larry A Gallagher
Laurence Rohmer
Mark R Pelletier
Mitchell J Brittnacher
Robert K Ernst
Scott A Shaffer
Shawn J Skerrett
Thomas Kalhorn
P2860
P356
10.1371/JOURNAL.PPAT.0040024
P577
2008-02-01T00:00:00Z